Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy

2016 ◽  
Vol 22 (1) ◽  
pp. 126-135 ◽  
Author(s):  
Hiroki Ishihara ◽  
Takafumi Yagisawa ◽  
Tsunenori Kondo ◽  
Kenji Omae ◽  
Toshio Takagi ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
Tumor Shrinkage ◽  
First Line ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Jun Teishima ◽  
Daiki Murata ◽  
Shogo Inoue ◽  
Tetsutaro Hayashi ◽  
Koji Mita ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitor ◽  
First Line ◽  
Early Progression
Sign in / Sign up

Export Citation Format

Share Document